USPTO Extends One Pilot Program But Declines to Extend Another
By EsqSocial Corporation 18/02/19
Last month, in Federal Register notices published on the same day (84 Fed. Reg. 411), the U.S. Patent and Trademark Office announced that it was extending the Cancer Immunotherapy Pilot Program, but that it had decided to discontinue the Extended...
By: McDonnell Boehnen Hulbert & Berghoff LLP